Caricamento...
Fibroblast growth factor 21 mediates glycemic regulation by hepatic JNK
The cJun NH(2)-terminal kinase (JNK) signaling pathway is implicated in metabolic syndrome, including dysregulated blood glucose concentration and insulin resistance. Fibroblast growth factor 21 (FGF21) is a target of the hepatic JNK signaling pathway and may contribute to the regulation of glycemia...
Salvato in:
| Pubblicato in: | Cell Rep |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794343/ https://ncbi.nlm.nih.gov/pubmed/26947074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2016.02.026 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|